Literature DB >> 18043684

The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.

S V Vormfelde, M R Toliat, M Schirmer, I Meineke, P Nürnberg, J Brockmöller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18043684     DOI： 10.1038/sj.clpt.6100404

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  12 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Prediction of the effects of genetic polymorphism on the pharmacokinetics of CYP2C9 substrates from in vitro data.

Authors:  Makiko Kusama; Kazuya Maeda; Koji Chiba; Akinori Aoyama; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2008-12-12       Impact factor: 4.200

Review 3.  The role of transporters in the pharmacokinetics of orally administered drugs.

Authors:  Sarah Shugarts; Leslie Z Benet
Journal:  Pharm Res       Date:  2009-06-30       Impact factor: 4.200

Review 4.  Pharmacogenetics in chronic heart failure: new developments and current challenges.

Authors:  Jasmine A Talameh; David E Lanfear
Journal:  Curr Heart Fail Rep       Date:  2012-03

5.  Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.

Authors:  Eline M Rodenburg; Bruno H Ch Stricker; Loes E Visser
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

6.  Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates.

Authors:  Yi M Weaver; Bruno Hagenbuch
Journal:  J Membr Biol       Date:  2010-09-04       Impact factor: 1.843

7.  Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms.

Authors:  Seung-Hyun Jeong; Ji-Hun Jang; Hea-Young Cho; Yong-Bok Lee
Journal:  Pharmaceutics       Date:  2022-04-01       Impact factor: 6.525

Review 8.  Impact of OATP transporters on pharmacokinetics.

Authors:  A Kalliokoski; M Niemi
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers.

Authors:  Dierk Werner; Ulrike Werner; Annett Meybaum; Boris Schmidt; Sumaira Umbreen; Anton Grosch; Heiko G Lestin; Bernhard Graf; Oliver Zolk; Martin F Fromm
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 10.  Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

Authors:  Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  Eur J Clin Pharmacol       Date:  2008-01-26       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.